IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding IGC Pharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 28 | 35 | +7 |
| Shares | 3.04M | 5.44M | +2.40M (+79.1%) |
| Value | $929.4K | $2.27M | +$1.34M (+143.8%) |
New holders (9)
Institutions that held IGC Pharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 60,258 | $25.0K | 0.00% |
| Fisher Asset Management, LLC | 43,400 | $18.1K | 0.00% |
| Gsa Capital Partners LLP | 27,821 | $12.0K | 0.00% |
| Wolverine Trading, LLC | 18,479 | $7.76K | 0.00% |
| Susquehanna International Group, LLP | 13,962 | $5.82K | 0.00% |
| Thompson Davis & Co., Inc. | 10,000 | $4.17K | 0.00% |
| Baader Bank INC | 13,961 | $3.60K | 0.00% |
| Caitlin John, LLC | 200 | $83 | 0.00% |
| Farther Finance Advisors, LLC | 100 | $42 | 0.00% |
Sold out (2)
Institutions that held IGC Pharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Jane Street Group, LLC | 13,316 | $4.08K |
| Raymond James Financial Inc | 178 | $55 |